Literature DB >> 26003525

Expression, purification and preliminary crystallographic studies of human glutamate oxaloacetate transaminase 1 (GOT1).

Xiuping Jiang1, Haiyang Chang2, Yong Zhou3.   

Abstract

Glutamate oxaloacetate transaminase (GOT) catalyzes the reversible reaction of l-aspartate and α-ketoglutarate into oxaloacetate and L-glutamate and plays a key role in carbon and nitrogen metabolism in all organisms. In human tissues, GOTs are pyridoxal 5'-phosphate-dependent (PLP) enzymes which exist in cytoplasm and mitochondrial forms, GOT1 and GOT2, respectively. GOT1 expression correlates with the growth of several tumors because cancer cells can utilize the amino acid glutamine to fuel anabolic processes, and therefore, GOT1 represents a new therapeutic target in cancer. In this work, human GOT1 was expressed in Escherichia coli periplasmic space, and purified by a combination of His-tag immobilized metal-ion affinity chromatography and anion exchange chromatography. Optimal activity of the enzyme occurred at a temperature of 37 °C and a pH of 7.5. Cations such as Na(+), K(+) and Mg(2+) slightly inhibited the activity of recombinant human GOT1, while Zn(2+), Mn(2+), Cu(2+), Ni(2+), Co(2+) and Ca(2+) had stronger inhibitory effects. Crystals of human GOT1 were grown using the hanging-drop vapor diffusion method at 4°C with 0.1M Bis-Tris pH 6.0% and 21% (w/v) PEG 3350. The crystals diffracted to 2.99Å resolution and belonged to space group P43212 with the unit cell parameters a = b = 93.4, c = 107.4Å, α = β = γ = 90°.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aspartate aminotransferase; Cancer metabolism; Expression; Glutamate oxaloacetate transaminase; Glutamine addiction; X-ray crystallography

Mesh:

Substances:

Year:  2015        PMID: 26003525     DOI: 10.1016/j.pep.2015.05.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.

Authors:  Huitao Wang; Kewei Fang; Jinsong Zhang; Yongming Jiang; Guang Wang; Haiyan Zhang; Tao Chen; Xin Shi; Yuhang Li; Fei Duan; Jianhe Liu
Journal:  Int Urol Nephrol       Date:  2017-05-26       Impact factor: 2.370

2.  Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.

Authors:  Yueying Yang; Mengzhu Zheng; Fei Han; Lei Shang; Mingxue Li; Xiaoxia Gu; Hua Li; Lixia Chen
Journal:  J Mol Med (Berl)       Date:  2022-02-25       Impact factor: 4.599

3.  CircGOT1 promotes cell proliferation, mobility, and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer.

Authors:  Shasha Zhou; Zhiyuan Guo; Xueli Lv; Xueqiang Zhang
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

4.  Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors.

Authors:  Melissa C Holt; Zahra Assar; Reza Beheshti Zavareh; Lin Lin; Justin Anglin; Oksana Mashadova; Daniel Haldar; Edouard Mullarky; Daniel M Kremer; Lewis C Cantley; Alec C Kimmelman; Adam J Stein; Luke L Lairson; Costas A Lyssiotis
Journal:  Biochemistry       Date:  2018-11-12       Impact factor: 3.162

5.  The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes.

Authors:  Giacomo Zoppini; Vittorio Cacciatori; Carlo Negri; Vincenzo Stoico; Giuseppe Lippi; Giovanni Targher; Enzo Bonora
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis.

Authors:  Mingming Jin; Chunzi Shi; Qian Hua; Tian Li; Chen Yang; Yue Wu; Licong Zhao; Hao Yang; Jiaqi Zhang; Cheng Hu; Gang Huang
Journal:  Aging (Albany NY)       Date:  2020-06-04       Impact factor: 5.682

7.  Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.

Authors:  Safiah Ibrahim Althurwi; Jun Q Yu; Philip Beale; Fazlul Huq
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.